Eli Lilly (LLY) PT Raised to $580 at Credit Suisse
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,233.66 --0%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 10
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 10
Join SI Premium – FREE
Credit Suisse analyst Trung Huynh raised the price target on Eli Lilly (NYSE: LLY) to $580.00 (from $490.00) while maintaining a Outperform rating.
You May Also Be Interested In
- PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
- Box, Inc. (BOX) PT Raised to $50 at DA Davidson
- Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
